{"id":"autologous-dc-vaccine","safety":{"commonSideEffects":[{"rate":"20%","effect":"Fatigue"},{"rate":"15%","effect":"Fever"},{"rate":"10%","effect":"Chills"}]},"_chembl":{"chemblId":"CHEMBL3931570","moleculeType":"Small molecule","molecularWeight":"307.39"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Autologous DC vaccines work by stimulating the body's own immune system to recognize and attack cancer cells. Dendritic cells are isolated from the patient, loaded with tumor antigens, and then reinfused to trigger an immune response.","oneSentence":"Stimulates an immune response against cancer cells","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T02:29:43.271Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Melanoma"}]},"trialDetails":[{"nctId":"NCT04801147","phase":"PHASE1, PHASE2","title":"Immunotherapy With Autologous Tumor Lysate-Loaded Dendritic Cells In Patients With Newly Diagnosed Glioblastoma Multiforme","status":"COMPLETED","sponsor":"Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta","startDate":"2010-06-26","conditions":"Glioblastoma","enrollment":76},{"nctId":"NCT06254326","phase":"PHASE1","title":"ADAGiO: Adoptive Cellular Therapy for the TreAtment of Recurrent OliGodendrogliOma (OG) Adult Patients","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Florida","startDate":"2024-09-19","conditions":"Recurrent Oligodendroglioma, Progressive Oligodendroglioma","enrollment":12},{"nctId":"NCT04335890","phase":"PHASE1","title":"IKKb-matured, RNA-loaded Dendritic Cells for Metastasised Uveal Melanoma","status":"COMPLETED","sponsor":"Hasumi International Research Foundation","startDate":"2020-09-24","conditions":"Melanoma, Uveal Metastatic","enrollment":17},{"nctId":"NCT03334305","phase":"PHASE1","title":"Adoptive Cellular Therapy in Pediatric Patients With High-grade Gliomas","status":"TERMINATED","sponsor":"University of Florida","startDate":"2018-05-16","conditions":"Malignant Glioma, High Grade Glioma","enrollment":18},{"nctId":"NCT07374029","phase":"PHASE1","title":"Adoptive T Cell Therapy With DC/AML Fusion Vaccine Plus Decitabine and Venetoclax in AML","status":"NOT_YET_RECRUITING","sponsor":"David Avigan","startDate":"2026-07","conditions":"Acute Myeloid Leukemia, Acute Myeloid Leukemia, in Relapse","enrollment":30},{"nctId":"NCT07365280","phase":"PHASE2","title":"Neoantigen-Pulsed Autologous Dendritic Cell Vaccine Combined With Temozolomide for Newly Diagnosed Glioblastoma","status":"NOT_YET_RECRUITING","sponsor":"ZSky Biotech Inc","startDate":"2026-01-09","conditions":"Glioblastoma","enrollment":78},{"nctId":"NCT00625755","phase":"PHASE1, PHASE2","title":"A Phase I/II Study to Assess the Safety and Efficacy of Vaccinations With Allogeneic Dendritic Cells: Autologous Tumor-Derived Cells Subjected to Electrofusions in Patients With AJCC Stage IV Renal Cell Carcinoma","status":"COMPLETED","sponsor":"Beth Israel Deaconess Medical Center","startDate":"2002-12","conditions":"Renal Cell Carcinoma","enrollment":40},{"nctId":"NCT07307053","phase":"PHASE1, PHASE2","title":"Rare Tumor Focused Platform Study of Innovative Therapies and Technologies (PLATFORM2)","status":"NOT_YET_RECRUITING","sponsor":"Cancer Institute and Hospital, Chinese Academy of Medical Sciences","startDate":"2026-01-01","conditions":"Rare Malignant Neoplasm, Advanced Solid Tumors, Metastatic Solid Tumors","enrollment":600},{"nctId":"NCT06514898","phase":"PHASE1","title":"Adoptive T Cell Therapy, DC Vaccines, and Hematopoietic Stem Cells Combined With Immune checkPOINT Blockade in Patients With Medulloblastoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Florida","startDate":"2025-05-05","conditions":"Recurrent Group 3 Medulloblastoma, Recurrent Group 4 (Non-SHH/Non-WNT) Medulloblastoma","enrollment":12},{"nctId":"NCT07260058","phase":"PHASE1, PHASE2","title":"Immune Cell Therapy for Advanced Solid Tumors","status":"NOT_YET_RECRUITING","sponsor":"Liaoning Medical Diagnosis and Treatment Technology Research and Development Co., Ltd.","startDate":"2025-12-01","conditions":"Lung Cancer (Locally Advanced or Metastatic), Liver Cancer (Locally Advanced or Metastatic), Colorectal Cancer (Locally Advanced or Metastatic)","enrollment":48},{"nctId":"NCT05631899","phase":"PHASE1","title":"CAR-DC Vaccine and ICIs in Local Advanced/Metastatic Solid Tumors","status":"ACTIVE_NOT_RECRUITING","sponsor":"Chinese PLA General Hospital","startDate":"2023-04-03","conditions":"Solid Tumor, Adult, EphA2 Overexpression, KRAS G12V","enrollment":9},{"nctId":"NCT05773859","phase":"PHASE1, PHASE2","title":"NEOadjuvant Dendritic Cell Vaccination for Ovarian Cancer","status":"RECRUITING","sponsor":"Radboud University Medical Center","startDate":"2023-03-17","conditions":"Epithelial Ovarian Cancer, Ovarian Carcinoma","enrollment":10},{"nctId":"NCT00510497","phase":"PHASE1, PHASE2","title":"Autologous Dendritic Cell Vaccine in HIV1 Infection","status":"COMPLETED","sponsor":"Sharon Riddler","startDate":"2007-07","conditions":"HIV Infections","enrollment":11},{"nctId":"NCT06100705","phase":"PHASE2","title":"Sipuleucel-T Combined With Bipolar Androgen Therapy in Men With mCRPC","status":"RECRUITING","sponsor":"Yale University","startDate":"2023-12-20","conditions":"Metastatic Castration-resistant Prostate Cancer","enrollment":26},{"nctId":"NCT03396575","phase":"PHASE1","title":"Brain Stem Gliomas Treated With Adoptive Cellular Therapy During Focal Radiotherapy Recovery Alone or With Dose-intensified Temozolomide (Phase I)","status":"TERMINATED","sponsor":"University of Florida","startDate":"2018-07-17","conditions":"Diffuse Intrinsic Pontine Glioma (DIPG), Brain Stem Glioma","enrollment":11},{"nctId":"NCT03758625","phase":"PHASE1","title":"Comparison of Dendritic Cell-Based Therapeutic Vaccine Strategies for HIV Functional Cure","status":"COMPLETED","sponsor":"Sharon Riddler","startDate":"2019-01-02","conditions":"HIV Infections","enrollment":40},{"nctId":"NCT06175221","phase":"PHASE2","title":"Autologous TLPO Vaccine Basket","status":"TERMINATED","sponsor":"Elios Therapeutics, LLC","startDate":"2023-11-29","conditions":"Tumor, Solid, Tumor Metastasis, Cancer","enrollment":63},{"nctId":"NCT04201873","phase":"PHASE1","title":"Pembrolizumab and a Vaccine (ATL-DC) for the Treatment of Surgically Accessible Recurrent Glioblastoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Jonsson Comprehensive Cancer Center","startDate":"2020-01-08","conditions":"Recurrent Glioblastoma","enrollment":40},{"nctId":"NCT02775292","phase":"PHASE1","title":"Gene-Modified T Cells, Vaccine Therapy, and Nivolumab in Treating Patients With Stage IV or Locally Advanced Solid Tumors Expressing NY-ESO-1","status":"COMPLETED","sponsor":"Jonsson Comprehensive Cancer Center","startDate":"2017-01-03","conditions":"Adult Solid Neoplasm, Childhood Solid Neoplasm, Metastatic Neoplasm","enrollment":1},{"nctId":"NCT04523688","phase":"PHASE2","title":"Vaccination With Autologous Dendritic Cells Loaded With Autologous Tumour Homogenate in Glioblastoma","status":"RECRUITING","sponsor":"Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS","startDate":"2021-03-25","conditions":"Glioblastoma, Vaccination","enrollment":28},{"nctId":"NCT07068555","phase":"PHASE1, PHASE2","title":"Prostate Cancer Vaccines","status":"RECRUITING","sponsor":"Shenzhen Geno-Immune Medical Institute","startDate":"2025-06-15","conditions":"Prostate Cancer Indications","enrollment":30},{"nctId":"NCT05195619","phase":"PHASE1","title":"Personalized DC Vaccines in Non Small Cell Lung Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Centre Hospitalier Universitaire Vaudois","startDate":"2022-03-22","conditions":"Non-small Cell Lung Cancer","enrollment":16},{"nctId":"NCT00683670","phase":"PHASE1","title":"Dendritic Cells (White Blood Cells) Vaccination for Advanced Melanoma","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2008-08","conditions":"Melanoma","enrollment":17},{"nctId":"NCT02432378","phase":"PHASE1, PHASE2","title":"Intensive Locoregional Chemoimmunotherapy for Recurrent Ovarian Cancer Plus Intranodal DC Vaccines","status":"TERMINATED","sponsor":"Roswell Park Cancer Institute","startDate":"2015-09-04","conditions":"Cancer of Ovary, Cancer of the Ovary, Neoplasms, Ovarian","enrollment":25},{"nctId":"NCT05127824","phase":"PHASE2","title":"Autologous Dendritic Cell Vaccine in Kidney Cancer","status":"RECRUITING","sponsor":"Jodi Maranchie","startDate":"2023-07-06","conditions":"Carcinoma, Renal Cell","enrollment":42},{"nctId":"NCT04078269","phase":"PHASE1","title":"MIDRIXNEO-LUNG Dendritic Cell Vaccine in Patients With Non-small Cell Lung Cancer","status":"COMPLETED","sponsor":"University Hospital, Ghent","startDate":"2019-08-26","conditions":"Non-small Cell Lung Cancer","enrollment":6},{"nctId":"NCT05964361","phase":"PHASE1, PHASE2","title":"First-in-human Interleukin-15-transpresenting Wilms' Tumor Protein 1-targeting Autologous Dendritic Cell Vaccination in Cancer Patients","status":"ACTIVE_NOT_RECRUITING","sponsor":"University Hospital, Antwerp","startDate":"2023-12-06","conditions":"Esophageal Cancer, Pancreas Cancer, Ovarian Cancer","enrollment":10},{"nctId":"NCT03688178","phase":"PHASE2","title":"DC Migration Study to Evaluate TReg Depletion In GBM Patients With and Without Varlilumab","status":"ACTIVE_NOT_RECRUITING","sponsor":"Annick Desjardins, MD","startDate":"2020-08-26","conditions":"Glioblastoma","enrollment":43},{"nctId":"NCT06749925","phase":"PHASE3","title":"Clinical Trial Assessing the Efficacy and Safety of Dendritic Cell-Based Immunotherapy for Glioblastoma","status":"NOT_YET_RECRUITING","sponsor":"University of Sao Paulo General Hospital","startDate":"2026-01","conditions":"Glioblastoma","enrollment":186},{"nctId":"NCT05714306","phase":"PHASE1, PHASE2","title":"PEP-DC and OC-DC Vaccine in High Grade Serous Ovarian Carcinoma","status":"WITHDRAWN","sponsor":"Centre Hospitalier Universitaire Vaudois","startDate":"2023-08-01","conditions":"Ovarian Carcinoma","enrollment":""},{"nctId":"NCT04627246","phase":"PHASE1","title":"Personalized Vaccine with SOC Chemo Followed by Nivo in Pancreatic Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Centre Hospitalier Universitaire Vaudois","startDate":"2020-09-11","conditions":"Pancreatic Adenocarcinoma","enrollment":14},{"nctId":"NCT04968366","phase":"PHASE1","title":"Safety & Efficacy of DC Vaccine and TMZ for the Treatment of Newly-diagnosed Glioblastoma After Surgery","status":"ACTIVE_NOT_RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2021-07-30","conditions":"Glioblastoma Multiforme of Brain","enrollment":11},{"nctId":"NCT06522919","phase":"PHASE2","title":"Sequential Immunochemotherapy Treatment with Pembrolizumab Plus Dendritic Cell (DC) Vaccine Followed by Trifluridine/Tipiracil Plus Bevacizumab in Refractory Mismatch-repair-proficient (pMMR) or Microsatellite-stable (MSS) Metastatic Colorectal Cancer","status":"RECRUITING","sponsor":"Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS","startDate":"2025-01-07","conditions":"Colorectal Cancer Metastatic, Microsatellite Stable Colorectal Carcinoma, Refractory Mismatch-repair-proficient (pMMR) Metastatic Colorectal Cancer","enrollment":36},{"nctId":"NCT01067287","phase":"PHASE2","title":"Blockade of PD-1 in Conjunction With the Dendritic Cell/Myeloma Vaccines Following Stem Cell Transplantation","status":"ACTIVE_NOT_RECRUITING","sponsor":"Beth Israel Deaconess Medical Center","startDate":"2010-03","conditions":"Multiple Myeloma","enrollment":35},{"nctId":"NCT03546361","phase":"PHASE1","title":"CCL21-Gene Modified Dendritic Cell Vaccine and Pembrolizumab in Treating Patients With Stage IV Non-small Cell Lung Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Jonsson Comprehensive Cancer Center","startDate":"2019-07-08","conditions":"Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8, Stage IVA Lung Cancer AJCC v8","enrollment":24},{"nctId":"NCT01973322","phase":"PHASE2","title":"Vaccination With Autologous Dendritic Cells Loaded With Autologous Tumor Lysate or Homogenate Combined With Immunomodulating Radiotherapy and/or Preleukapheresis IFN-alfa in Patients With Metastatic Melanoma: a Randomized \"Proof-of-principle\" Phase II Study","status":"COMPLETED","sponsor":"Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS","startDate":"2013-10-08","conditions":"Malignant Melanoma of Skin Stage III, Malignant Melanoma of Skin Stage IV","enrollment":34},{"nctId":"NCT02301611","phase":"PHASE2","title":"Phase IIB TL + YCWP + DC in Melanoma","status":"COMPLETED","sponsor":"Elios Therapeutics, LLC","startDate":"2015-01","conditions":"Melanoma","enrollment":187},{"nctId":"NCT05882305","phase":"EARLY_PHASE1","title":"KSD-101 Therapy for EBV-associated Lymphomas: an Exploratory Clinical Trial","status":"WITHDRAWN","sponsor":"Kousai Bio Co., Ltd.","startDate":"2023-06-10","conditions":"EBV-associated Lymphomas","enrollment":""},{"nctId":"NCT03546426","phase":"PHASE1","title":"Pembrolizumab Plus Autologous Dendritic Cell Vaccine in Patients with PD-L1 Negative Advanced Mesothelioma Who Have Failed Prior Therapies","status":"ACTIVE_NOT_RECRUITING","sponsor":"Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS","startDate":"2019-12-12","conditions":"Mesothelioma, Malignant, PD-L1 Negative, Advanced Cancer","enrollment":18},{"nctId":"NCT02649582","phase":"PHASE1, PHASE2","title":"Adjuvant Dendritic Cell-immunotherapy Plus Temozolomide in Glioblastoma Patients","status":"ACTIVE_NOT_RECRUITING","sponsor":"University Hospital, Antwerp","startDate":"2015-12","conditions":"Glioblastoma Multiforme of Brain","enrollment":20},{"nctId":"NCT04166006","phase":"PHASE2","title":"A Phase II Study on Adjuvant Vaccination with Dendritic Cells Loaded with Autologous Tumor Homogenate in Resected Stage IV Rare Cancers.","status":"RECRUITING","sponsor":"Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS","startDate":"2019-12-12","conditions":"Head Neck Tumors, Neuroendocrine Tumors, Soft Tissue Sarcoma","enrollment":51},{"nctId":"NCT03879512","phase":"PHASE1, PHASE2","title":"Autologous Dendritic Cells, Metronomic Cyclophosphamide and Checkpoint Blockade in Children With Relapsed HGG","status":"COMPLETED","sponsor":"Wuerzburg University Hospital","startDate":"2018-02-07","conditions":"Childhood Glioblastoma","enrollment":24},{"nctId":"NCT01204684","phase":"PHASE2","title":"Dendritic Cell Vaccine for Patients With Brain Tumors","status":"COMPLETED","sponsor":"Jonsson Comprehensive Cancer Center","startDate":"2010-10-08","conditions":"Glioma, Anaplastic Astrocytoma, Anaplastic Astro-oligodendroglioma","enrollment":24},{"nctId":"NCT01446731","phase":"PHASE2","title":"Dendritic Cell Vaccination and Docetaxel for Patients With Prostate Cancer","status":"COMPLETED","sponsor":"Inge Marie Svane","startDate":"2011-10","conditions":"Prostatic Neoplasms","enrollment":43},{"nctId":"NCT01898663","phase":"PHASE1, PHASE2","title":"DCs Vaccine Combined With Cytokine-induced Killer Cells in Patients With AML","status":"RECRUITING","sponsor":"Affiliated Hospital to Academy of Military Medical Sciences","startDate":"2013-06","conditions":"High-risk Soft Tissue Sarcoma","enrollment":30},{"nctId":"NCT04911621","phase":"PHASE1, PHASE2","title":"Adjuvant Dendritic Cell Immunotherapy for Pediatric Patients With High-grade Glioma or Diffuse Intrinsic Pontine Glioma","status":"ACTIVE_NOT_RECRUITING","sponsor":"University Hospital, Antwerp","startDate":"2021-09-10","conditions":"High Grade Glioma, Diffuse Intrinsic Pontine Glioma","enrollment":10},{"nctId":"NCT02728102","phase":"PHASE2","title":"Dendritic Cell/Myeloma Fusion Vaccine for Multiple Myeloma (BMT CTN 1401)","status":"COMPLETED","sponsor":"National Heart, Lung, and Blood Institute (NHLBI)","startDate":"2016-07","conditions":"Multiple Myeloma","enrollment":203},{"nctId":"NCT03927222","phase":"PHASE2","title":"Immunotherapy Targeted Against Cytomegalovirus in Patients With Newly-Diagnosed WHO Grade IV Unmethylated Glioma","status":"TERMINATED","sponsor":"Mustafa Khasraw, MBChB, MD, FRCP, FRACP","startDate":"2019-09-30","conditions":"Glioblastoma","enrollment":6},{"nctId":"NCT04487756","phase":"PHASE1, PHASE2","title":"Combination of Atezolizumab With Dendritic Cell Vaccine in Patients With Lung Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Instituto Oncológico Dr Rosell","startDate":"2021-03-17","conditions":"Extensive-stage Small Cell Lung Cancer","enrollment":20},{"nctId":"NCT01686334","phase":"PHASE2","title":"Efficacy Study of Dendritic Cell Vaccination in Patients With Acute Myeloid Leukemia in Remission","status":"ACTIVE_NOT_RECRUITING","sponsor":"Zwi Berneman","startDate":"2012-10","conditions":"Acute Myeloid Leukemia","enrollment":130},{"nctId":"NCT06097793","phase":"EARLY_PHASE1","title":"KSD-101 Therapy for EBV-associated Nasopharyngeal Carcinoma: an Exploratory Clinical Trial","status":"RECRUITING","sponsor":"Kousai Bio Co., Ltd.","startDate":"2023-12-04","conditions":"Nasopharyngeal Carcinoma","enrollment":12},{"nctId":"NCT02678741","phase":"PHASE1, PHASE2","title":"Multi-center Phase I/IIa Trial of an Autologous Tumor Lysate (TL) + Yeast Cell Wall Particles (YCWP) + Dendritic Cells (DC) Vaccine in Addition to Standard of Care Checkpoint Inhibitor of Choice in Metastatic Melanoma Patients With Measurable Disease.","status":"COMPLETED","sponsor":"Elios Therapeutics, LLC","startDate":"2016-02","conditions":"Metastatic Melanoma","enrollment":26},{"nctId":"NCT03671720","phase":"EARLY_PHASE1","title":"Personalized Vaccine Generated by Autologous Dendritic Cells Pulsed With Autologous Whole Tumor Cell Lysate Treat Advanced Solid Tumor Patients With High Tumor Mutation Burden","status":"WITHDRAWN","sponsor":"Capital Medical University","startDate":"2018-09-11","conditions":"Advanced Cancer, Metastatic Cancer","enrollment":""},{"nctId":"NCT05321940","phase":"PHASE1","title":"Safety Trial of STING-dependent Activators and Stimulated Dendritic Cells for Aggressive Relapsed/Refractory Leukemias","status":"WITHDRAWN","sponsor":"Juan C. Ramos, MD","startDate":"2023-11-30","conditions":"Refractory Leukemia, Relapsed Leukemia, Acute Myelogenous Leukemia","enrollment":""},{"nctId":"NCT03735589","phase":"PHASE1, PHASE2","title":"Specialized Immune Cells (nCTLs) and a Vaccine (Alpha-type-1 Polarized Dendritic Cells) in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer","status":"WITHDRAWN","sponsor":"Roswell Park Cancer Institute","startDate":"2023-12-15","conditions":"Stage II Fallopian Tube Cancer AJCC v8, Stage II Ovarian Cancer AJCC v8, Stage II Primary Peritoneal Cancer AJCC v8","enrollment":""},{"nctId":"NCT00082641","phase":"PHASE1, PHASE2","title":"Neoadjuvant/Adjuvant Chemotherapy, Vaccine & Adjuvant Radiation Therapy in p53-Overexpressing Stage III Breast Cancer","status":"COMPLETED","sponsor":"University of Nebraska","startDate":"2004-01-01","conditions":"Breast Cancer","enrollment":24},{"nctId":"NCT05635591","phase":"PHASE1","title":"KSD-101 Therapy for EBV-associated Haematologic Neoplasms: an Exploratory Clinical Trial","status":"UNKNOWN","sponsor":"Tongji Hospital","startDate":"2023-01-16","conditions":"EBV-associated Haematologic Neoplasms","enrollment":9},{"nctId":"NCT05631886","phase":"PHASE1","title":"Combination of CAR-DC Vaccine and ICIs in Malignant Tumors","status":"RECRUITING","sponsor":"Chinese PLA General Hospital","startDate":"2023-07-04","conditions":"Solid Tumor, Adult, Lymphoma, EphA2 Overexpression","enrollment":10},{"nctId":"NCT02366728","phase":"PHASE2","title":"DC Migration Study for Newly-Diagnosed GBM","status":"COMPLETED","sponsor":"Mustafa Khasraw, MBChB, MD, FRCP, FRACP","startDate":"2015-10-12","conditions":"Glioblastoma, Astrocytoma, Grade IV, Giant Cell Glioblastoma","enrollment":64},{"nctId":"NCT04386252","phase":"PHASE1, PHASE2","title":"Phase I-II Trial of Dendritic Cell Vaccine to Prevent COVID-19 in Adults","status":"WITHDRAWN","sponsor":"Aivita Biomedical, Inc.","startDate":"2023-01","conditions":"COVID-19","enrollment":""},{"nctId":"NCT00639639","phase":"PHASE1","title":"Vaccine Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme","status":"COMPLETED","sponsor":"Gary Archer Ph.D.","startDate":"2006-02-06","conditions":"Malignant Neoplasms of Brain","enrollment":42},{"nctId":"NCT02543749","phase":"PHASE1, PHASE2","title":"DC Vaccination in CML","status":"TERMINATED","sponsor":"Charite University, Berlin, Germany","startDate":"2014-07","conditions":"Myeloid Leukemia, Chronic","enrollment":1},{"nctId":"NCT01197625","phase":"PHASE1, PHASE2","title":"Vaccine Therapy in Curative Resected Prostate Cancer Patients","status":"UNKNOWN","sponsor":"Oslo University Hospital","startDate":"2010-09","conditions":"Prostate Cancer","enrollment":30},{"nctId":"NCT01730118","phase":"PHASE1","title":"Ad/HER2/Neu Dendritic Cell Cancer Vaccine Testing","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2013-03-04","conditions":"Breast Neoplasms, Breast Cancer, Adenocarcinomas","enrollment":33},{"nctId":"NCT02808416","phase":"PHASE1","title":"Personalized Cellular Vaccine for Brain Metastases (PERCELLVAC3)","status":"COMPLETED","sponsor":"Guangdong 999 Brain Hospital","startDate":"2016-03-01","conditions":"Brain Cancer, Neoplasm Metastases","enrollment":10},{"nctId":"NCT02808364","phase":"PHASE1","title":"Personalized Cellular Vaccine for Recurrent Glioblastoma (PERCELLVAC2)","status":"COMPLETED","sponsor":"Guangdong 999 Brain Hospital","startDate":"2016-03-01","conditions":"Glioblastoma","enrollment":10},{"nctId":"NCT05317325","phase":"PHASE1","title":"A Translational Study of Tumor Antigen-pulsed DC Vaccine for ESCC","status":"UNKNOWN","sponsor":"Sichuan University","startDate":"2022-04-01","conditions":"Esophageal Squamous Cell Carcinoma","enrollment":20},{"nctId":"NCT02362451","phase":"PHASE2","title":"Multi-Epitope TARP Peptide Autologous Dendritic Cell Vaccination in Men With Stage D0 Prostate Cancer","status":"TERMINATED","sponsor":"National Cancer Institute (NCI)","startDate":"2015-07-10","conditions":"Prostatic Neoplasms, Prostate Cancer","enrollment":7},{"nctId":"NCT04888611","phase":"PHASE2","title":"Neoadjuvant PD-1 Antibody Alone or Combined With DC Vaccines for Recurrent Glioblastoma","status":"UNKNOWN","sponsor":"Huashan Hospital","startDate":"2021-10-26","conditions":"Recurrent Glioblastoma","enrollment":40},{"nctId":"NCT00026624","phase":"PHASE1","title":"Safety/Immunogenicity of Immunizations of ALVAC-DC-SC vs ALVAC-SC","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"","conditions":"HIV Infections","enrollment":""},{"nctId":"NCT05000801","phase":"NA","title":"Clinical Study of DC-AML Cells in the Treatment of Acute Myeloid Leukemia","status":"RECRUITING","sponsor":"Affiliated Hospital to Academy of Military Medical Sciences","startDate":"2021-07-01","conditions":"Acute Myeloid Leukemia","enrollment":20},{"nctId":"NCT04999943","phase":"PHASE1","title":"Hypomemylating Agents Combination With eDC Therapy for Elderly Patients With Myelodysplastic Syndrome","status":"RECRUITING","sponsor":"Affiliated Hospital to Academy of Military Medical Sciences","startDate":"2021-07-01","conditions":"Myelodysplastic Syndromes, Dendritic Cell, Hypomethylating Agents","enrollment":40},{"nctId":"NCT00703105","phase":"PHASE2","title":"Ovarian Dendritic Cell Vaccine Trial","status":"UNKNOWN","sponsor":"Loyola University","startDate":"2008-10","conditions":"Ovarian Cancer","enrollment":36},{"nctId":"NCT04082182","phase":"PHASE1","title":"MIDRIX4-LUNG Dendritic Cell Vaccine in Patients With Metastatic Non-small Cell Lung Cancer","status":"UNKNOWN","sponsor":"University Hospital, Ghent","startDate":"2019-08-26","conditions":"Non-small Cell Lung Cancer Metastatic","enrollment":7},{"nctId":"NCT01302496","phase":"PHASE2","title":"Autologous TriMix-DC Therapeutic Vaccine in Combination With Ipilimumab in Patients With Previously Treated Unresectable Stage III or IV Melanoma","status":"COMPLETED","sponsor":"Bart Neyns","startDate":"2011-02","conditions":"Malignant Melanoma Stage III, Malignant Melanoma Stage IV","enrollment":39},{"nctId":"NCT00961844","phase":"PHASE1, PHASE2","title":"Trial for Vaccine Therapy With Dendritic Cells in Patients With Metastatic Malignant Melanoma","status":"TERMINATED","sponsor":"Steinar Aamdal","startDate":"2009-08","conditions":"Metastatic Malignant Melanoma","enrollment":15},{"nctId":"NCT01334047","phase":"PHASE1, PHASE2","title":"Trial of Vaccine Therapy in Recurrent Platinum Sensitive Ovarian Cancer Patients","status":"TERMINATED","sponsor":"Steinar Aamdal","startDate":"2011-04","conditions":"Recurrent Epithelial Ovarian Cancer","enrollment":5},{"nctId":"NCT03615404","phase":"PHASE1","title":"Cytomegalovirus (CMV) RNA-Pulsed Dendritic Cells for Pediatric Patients and Young Adults With WHO Grade IV Glioma, Recurrent Malignant Glioma, or Recurrent Medulloblastoma","status":"COMPLETED","sponsor":"Gary Archer Ph.D.","startDate":"2018-10-05","conditions":"Glioblastoma, Malignant Glioma, Medulloblastoma Recurrent","enrollment":11},{"nctId":"NCT04567069","phase":"PHASE1, PHASE2","title":"Safety and Efficacy Study for MG-7-DC Vaccine in Gastric Cancer Treatment","status":"UNKNOWN","sponsor":"The Second Hospital of Shandong University","startDate":"2020-09","conditions":"Gastric Cancer","enrollment":45},{"nctId":"NCT00601094","phase":"PHASE1","title":"Vaccine Therapy in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer","status":"COMPLETED","sponsor":"Jonsson Comprehensive Cancer Center","startDate":"2009-02-26","conditions":"Lung Cancer","enrollment":17},{"nctId":"NCT00005617","phase":"PHASE1","title":"Vaccine Therapy in Treating Patients With Stage IV or Relapsed Malignant Melanoma","status":"COMPLETED","sponsor":"Jonsson Comprehensive Cancer Center","startDate":"1997-07","conditions":"Melanoma","enrollment":""},{"nctId":"NCT00022334","phase":"PHASE1, PHASE2","title":"Vaccine Therapy in Treating Patients With Liver Cancer","status":"COMPLETED","sponsor":"Jonsson Comprehensive Cancer Center","startDate":"2001-01","conditions":"Liver Cancer","enrollment":33},{"nctId":"NCT00068510","phase":"PHASE1","title":"Vaccine Therapy in Treating Patients With Malignant Glioma","status":"COMPLETED","sponsor":"Jonsson Comprehensive Cancer Center","startDate":"2003-06","conditions":"Brain and Central Nervous System Tumors","enrollment":28},{"nctId":"NCT01312376","phase":"PHASE1","title":"Autologous T-Cells Combined With Autologous OC-DC Vaccine in Ovarian Cancer","status":"TERMINATED","sponsor":"Abramson Cancer Center at Penn Medicine","startDate":"2011-03","conditions":"Ovarian Carcinoma, Fallopian Tube Cancer, Primary Peritoneal Cancer","enrollment":18},{"nctId":"NCT02529072","phase":"PHASE1","title":"Nivolumab With DC Vaccines for Recurrent Brain Tumors","status":"COMPLETED","sponsor":"Gary Archer Ph.D.","startDate":"2016-01","conditions":"Malignant Glioma, Astrocytoma, Glioblastoma","enrollment":6},{"nctId":"NCT01239875","phase":"EARLY_PHASE1","title":"Vaccine Therapy With or Without Cryosurgery in Treating Patients With Residual, Relapsed, or Refractory B-Cell Non-Hodgkin Lymphoma","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2010-11","conditions":"Cutaneous B-cell Non-Hodgkin Lymphoma, Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue, Nodal Marginal Zone B-cell Lymphoma","enrollment":16},{"nctId":"NCT01883518","phase":"PHASE1, PHASE2","title":"Autologous Dendritic Cell Vaccine in Patients With Soft Tissue Sarcoma","status":"UNKNOWN","sponsor":"N.N. Petrov National Medical Research Center of Oncology","startDate":"2013-06","conditions":"Sarcoma, Neoplasms, Connective and Soft Tissue","enrollment":48},{"nctId":"NCT02820584","phase":"PHASE1","title":"A Phase I Study of Immunotherapy With GSC -Loaded Dendritic Cells in Patients With Recurrent Glioblastoma","status":"COMPLETED","sponsor":"Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta","startDate":"2016-09","conditions":"de Novo Glioblastoma","enrollment":20},{"nctId":"NCT01876212","phase":"PHASE2","title":"Dendritic Cell Vaccines + Dasatinib for Metastatic Melanoma","status":"COMPLETED","sponsor":"Walter J. Storkus","startDate":"2014-05-16","conditions":"Metastatic Melanoma","enrollment":15},{"nctId":"NCT04002804","phase":"PHASE1","title":"Immunotherapy With Autologous Tumor Lysate-Loaded Dendritic Cells In Patients With Recurrence Of Glioblastoma Multiforme","status":"TERMINATED","sponsor":"Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta","startDate":"2010-04","conditions":"Glioblastoma","enrollment":26},{"nctId":"NCT03119025","phase":"PHASE1, PHASE2","title":"Autologous Dendritic Cell Vaccine for Treatment of Patients With Chronic HCV-Infection","status":"COMPLETED","sponsor":"Russian Academy of Medical Sciences","startDate":"2015-05","conditions":"Hepatitis C, Chronic, Liver Diseases, Hepatitis","enrollment":10},{"nctId":"NCT03870113","phase":"PHASE1","title":"DC Vaccines Targeting HPV16/18 E6/E7 Protein to Regress CINI/CIN2","status":"UNKNOWN","sponsor":"Shenzhen People's Hospital","startDate":"2019-04-01","conditions":"Cervical Intraepithelial Neoplasia","enrollment":80},{"nctId":"NCT03871205","phase":"PHASE1","title":"Neoantigen-primed DC Vaccines Therapy for Refractory Lung Cancer","status":"UNKNOWN","sponsor":"Shenzhen People's Hospital","startDate":"2019-04-01","conditions":"Carcinoma, Non-Small Cell Lung, Carcinoma, Small Cell Lung","enrollment":30},{"nctId":"NCT02070406","phase":"PHASE1","title":"Gene-Modified T Cells, Vaccine Therapy, and Ipilimumab in Treating Patients With Locally Advanced or Metastatic Malignancies","status":"TERMINATED","sponsor":"Jonsson Comprehensive Cancer Center","startDate":"2014-07-17","conditions":"Unspecified Adult Solid Tumor, Protocol Specific","enrollment":4},{"nctId":"NCT03226236","phase":"PHASE2","title":"Vaccination With Dendritic Cells Pulsed With Autologous Tumor Homogenate in Combination With HD-IL2 and Immunomodulating Radiotherapy in Metastatic RCC","status":"WITHDRAWN","sponsor":"Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS","startDate":"2016-03","conditions":"Carcinoma, Renal Cell, Vaccination, Secondary","enrollment":""},{"nctId":"NCT02049489","phase":"PHASE1","title":"A Study of ICT-121 Dendritic Cell Vaccine in Recurrent Glioblastoma","status":"COMPLETED","sponsor":"Precision Life Sciences Group","startDate":"2013-12","conditions":"Glioblastoma Multiforme","enrollment":20},{"nctId":"NCT00085436","phase":"PHASE2","title":"DC Vaccine Combined With IL-2 and IFNα-2a in Treating Patients With mRCC","status":"COMPLETED","sponsor":"Dartmouth-Hitchcock Medical Center","startDate":"2003-12","conditions":"Kidney Cancer","enrollment":18},{"nctId":"NCT01132014","phase":"EARLY_PHASE1","title":"Autologous OC-DC Vaccine in Ovarian Cancer","status":"COMPLETED","sponsor":"Abramson Cancer Center at Penn Medicine","startDate":"2010-05","conditions":"Chemotherapy, Tumor, Ovarian Cancer","enrollment":67},{"nctId":"NCT02332889","phase":"PHASE1, PHASE2","title":"Phase I/II: Decitabine/Vaccine Therapy in Relapsed/Refractory Pediatric High Grade Gliomas/Medulloblastomas/CNS PNETs","status":"TERMINATED","sponsor":"University of Louisville","startDate":"2015-04","conditions":"Gliomas, Medulloblastoma, Neuroectodermal Tumors, Primitive","enrollment":1},{"nctId":"NCT01574222","phase":"PHASE1","title":"A Vaccine Trial for Patients With Stage IIIB, IV, or Recurrent Non-Small Cell Lung Cancer","status":"TERMINATED","sponsor":"VA Office of Research and Development","startDate":"2011-10-01","conditions":"Non-Small Cell Lung Cancer (NSCLC)","enrollment":1}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_2","status":"active","brandName":"Autologous DC vaccine","genericName":"Autologous DC vaccine","companyName":"Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS","companyId":"istituto-romagnolo-per-lo-studio-dei-tumori-dino-amadori-irst-s-r-l-irccs","modality":"Biologic","firstApprovalDate":"","aiSummary":"Stimulates an immune response against cancer cells Used for Melanoma.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}